FB Pixel no scriptDeep Tech | KrASIA
MENU
KrASIA

Deep Tech

Insights

After Hengrui’s USD 500 million deal with GSK, which biotech firms are next in line?

As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

6 mins read
  • Two new features expand Kling AI’s capabilities, pushing it closer to production-grade applications.

    News

    Kling AI rolls out new features to streamline generative content workflows

    2 mins read

Most Recent

See All